Korean Red Ginseng Rootlets Decrease Acute Postprandial Glycemia: Results from Sequential Preparation- and Dose-Finding Studies
John L. Sievenpiper, PhD,
Mi-Kyung Sung, PhD,
Marco Di Buono, PhD,
Kwang Seung-Lee, PhD,
Ki Yeul Nam, PhD,
John T. Arnason, PhD,
Lawrence A. Leiter, MD and
Vladimir Vuksan, PhD
Department of Nutritional Sciences, Faculty of Medicine, University of Toronto (J.L.S., L.A.L., V.V.)
Risk Factor Modification Centre, St. Michaels Hospital (J.L.S., M.D., L.A.L., V.V.), Toronto
Department of Biology, Faculty of Science, University of Ottawa, Ottawa (J.T.A.), CANADA
Department of Food and Nutrition, Sookmyung Womens University, Seoul (M.S.)
Korea Ginseng Manufacturing Plant, National Agricultural Cooperative Federation, Chung-buk (K.S.L.)
Korean Ginseng and Tobacco Research Institute, Daejeon (K.Y.N.), KOREA

View larger version (13K):
[in a new window]
|
Fig. 3. Effect of overall Korean red ginseng (KRG) rootlets treatment (mean of 2 g, 4 g, 6 g doses) on postprandial glycemia. The line plots and bars in the represent the incremental change and area under the curve (AUC) for placebo () or the mean of the 3 KRG-rootlets doses ( ) administered 40-min before a 50 g-OGTT in 12 healthy nondiabetic subjects (sex: 9M:3F, age: 29 ± 3 y, BMI: 22.5 ± 1 kg/m2). P-values reported in the base of the plot area are for the main effects of treatment and time and their interactions from repeated measures two-way ANOVA. Data are mean ± SEM.
|
|
Copyright © 2006 by the American College of Nutrition.